India Globalization Capital, Inc. engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies. The Legacy Infrastructure segment trades in infrastructure commodities, such as steel and iron ore; and rents heavy equipment. The Medical Cannabis Based Alternative Therapies segment offers IGC-501 for indications of neuropathic pain; Serosapse for indications of Parkinson's and other central nervous system disorders; Caesafin for seizures in cats and dogs; and Natrinol for indications of cancer and AIDS induced nausea and vomiting, as well as Hyalolex for Alzheimer's patients. The company was founded in 2005 and is based in Bethesda, Maryland.
Industry, Sector and Symbol
Industry Steel & Iron
Sub-IndustryN/A
SectorBasic Materials
Phone+1-301-9830998
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
OptionableOptionable
India Globalization Capital (NYSEAMERICAN:IGC) Frequently Asked Questions
What is India Globalization Capital's stock symbol?
India Globalization Capital trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "IGC."
How were India Globalization Capital's earnings last quarter?
India Globalization Capital, Inc. (NYSEAMERICAN:IGC) issued its quarterly earnings data on Tuesday, October, 16th. The construction company reported ($0.03) EPS for the quarter. The construction company had revenue of $0.81 million for the quarter. View India Globalization Capital's Earnings History.
When is India Globalization Capital's next earnings date?
Has India Globalization Capital been receiving favorable news coverage?
News articles about IGC stock have been trending positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. India Globalization Capital earned a daily sentiment score of 2.3 on InfoTrie's scale. They also gave news headlines about the construction company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the company's share price in the near term.
Who are some of India Globalization Capital's key competitors?
Who are India Globalization Capital's key executives?
India Globalization Capital's management team includes the folowing people:
- Mr. Ram Mukunda, Exec. Chairman, Pres & CEO (Age 59)
- Ms. Claudia Grimaldi, VP & Principal Financial Officer (Age 47)
- Mr. Rohit Goel, Principal Accounting Officer (Age 24)
- Dr. Jagadeesh Rao, Scientific Officer (Age 51)
- Mr. Shajy Mathilakathu, Co-Principal Financial & Accounting Officer (Age 50)
How do I buy shares of India Globalization Capital?
Shares of IGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is India Globalization Capital's official website?
How can I contact India Globalization Capital?
India Globalization Capital's mailing address is 4336 Montgomery Ave, BETHESDA, MD 20814-4443, United States. The construction company can be reached via phone at +1-301-9830998.
MarketBeat Community Rating for India Globalization Capital (NYSEAMERICAN IGC)
MarketBeat's community ratings are surveys of what our community members think about India Globalization Capital and other stocks. Vote "Outperform" if you believe IGC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IGC will underperform the S&P 500 over the long term. You may vote once every thirty days.
